Literature DB >> 22149072

Ocular motor dysfunction in Parry-Romberg syndrome: four cases.

Christina R Prescott1, M Joshua Hasbani, Andrew J Levada, Jonathan E Silbert, Jacqueline M S Winterkorn, Robert L Lesser.   

Abstract

The authors describe four patients with Parry-Romberg syndrome (PRS) who had abnormal eye movements, ptosis, and facial hemiatrophy. There were delays in diagnosis in all cases, often requiring multiple imaging studies, prior to diagnosis of PRS. These cases demonstrate the variable ophthalmic manifestations of PRS, which can lead to difficulty in diagnosis. Case 1 was a 23-year-old woman with lateral rectus paresis who presented with horizontal diplopia and developed ptosis and facial hemiatrophy. Case 2 was a 28-year-old woman with medial rectus weakness adjusted to diplopia by head turn and gaze preference. Case 3 was a 68-year-old woman who presented with dry eye symptoms and was noted to prefer right gaze and have left hemifacial atrophy. Case 4 was a 68-year-old woman who presented with ptosis, enophthalmos, and restriction of up gaze. The ocular motor defect in all of these cases is best explained by muscle fibrosis rather than nerve paresis. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Year:  2011        PMID: 22149072     DOI: 10.3928/01913913-20111129-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  3 in total

1.  Neurological Manifestations in Parry-Romberg Syndrome: 2 Case Reports.

Authors:  Justine Vix; Stéphane Mathis; Mathieu Lacoste; Rémy Guillevin; Jean-Philippe Neau
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

2.  Parry Romberg syndrome presenting with a giant intracranial aneurysm: a case report.

Authors:  Ilse H de Lange; Anna Mt van Oploo; Feico Jj Halbertsma; F George Roos; Levinus A Bok
Journal:  Oxf Med Case Reports       Date:  2017-05-30

3.  Progressive hemifacial atrophy with characteristic ocular manifestations in a Chinese patient with a CRB1 mutation.

Authors:  Jinghua Liu; Ying Liu; Liming Wang; Xiaohan Zhang; Peng Hao; Xuan Li
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.